Recursive Adaptation - Addiction Medicine and Policy

Home
CASPR.org
Archive
About
Don't let your dentist give you opioids
New RCT shows Tylenol plus Ibuprofen works better than Vicodin
 • 
Noah Davis
"The change was immediate: I lost all desire to drink alcohol on Mounjaro."
From more than a dozen drinks a day to zero overnight.
 • 
Noah Davis
3
Can GLP-1s reduce crime? We are planning a study to find out.
A support plus GLP-1 study that confronts the cycle of addiction and incarceration amongst women.
 • 
Nick Horton
RFK Jr and MAHA, Alcohol, Soda, and Lung Cancer
Upstream, upstream, upstream
 • 
Nicholas Reville
My podcast episode with Chris Hayes
Chris interviewed me about addiction medicine, GLP-1s, and innovation policy.
 • 
Nicholas Reville
GLP-1 Event and what CASPR has been working on
We've been very, very, very busy!
 • 
Nicholas Reville
Addiction News and Updates
The cocaine boom, our new FAS publication, alcohol+cancer, and more.
 • 
Nicholas Reville
“Wegovy rewired my brain. I have no desire for cigarettes and minimal desire for alcohol.”
How a Fortune 50 VP controlled his "20 pack-year" and a 5- to 6-drink a night habits.
 • 
Noah Davis

December 2024

Addiction Predictions for 2025 and Beyond
Predictions on painkillers, GLP-1s for addiction, compounding and more.
 • 
Nicholas Reville
16
Addiction News Updates
Lilly studying GLP-1s, alcohol deaths double, AstaZeneca cuts their OUD drug
 • 
Nicholas Reville
How an addiction medicine doctor has used tirzepatide to transform his own life, and translate that experience to benefit his patients.
"Everything changed when I was prescribed tirzepatide in 2019."
 • 
Noah Davis
An Innovation Agenda for Addiction
from CASPR and Institute for Progress (IFP)
 • 
Nicholas Reville
 and 
Willy Chertman
© 2025 CASPR
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture